Zelluna Immunotherapy

Oslo, Norway

Zelluna Immunotherapy is a privately owned Norwegian biopharmaceutical company.

$6.1M raised

Jun 2026

Post-IPO Equity

Biotechnology Health Care Medical Pharmaceutical

Top Investors

Takeda Ventures Birk Venture

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Zelluna Immunotherapy

How much funding has Zelluna Immunotherapy raised?

Zelluna Immunotherapy has raised $6.1M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.

Who are Zelluna Immunotherapy's investors?

Zelluna Immunotherapy's investors include Takeda Ventures, Birk Venture.

Where is Zelluna Immunotherapy headquartered?

Zelluna Immunotherapy is headquartered in Oslo, Norway.

What does Zelluna Immunotherapy do?

Zelluna Immunotherapy is a privately owned Norwegian biopharmaceutical company.

What stage is Zelluna Immunotherapy at?

Zelluna Immunotherapy is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 17, 2026.

MLA

"Zelluna Immunotherapy — Funding & Investors." VCBacked, June 17, 2026, https://www.vcbacked.co/company/zelluna-immunotherapy. Accessed July 2, 2026.

APA

VCBacked. (2026). Zelluna Immunotherapy — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/zelluna-immunotherapy

Wikipedia (cite web)

{{cite web |title=Zelluna Immunotherapy — Funding & Investors |url=https://www.vcbacked.co/company/zelluna-immunotherapy |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 17, 2026.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K